Cardiac Monitoring Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2030)

Cardiac Monitoring Market Trends & Growth Drivers

Technological Advancement Are Key Trends in Market

• Technological advancements are key trends in the market revolutionizing cardiac monitoring, enhancing both accuracy and accessibility.
• Advanced heart rate monitoring and ECG features are available in the newest generation of wearable , such as Fitbit Sense 3 and Apple Watch Series 9.
• These devices give users access to real-time cardiac data and are capable of identifying irregularities such as atrial fibrillation.
• Additionally, they interact with health apps to communicate data with medical professionals, increasing the accessibility and customization of cardiac monitoring.
• The application of AI and ML is improving data analysis and forecasting capacities, which is revolutionizing cardiac monitoring.
• For instance, AliveCor's KardiaMobile 7 uses AI to analyze ECG data, giving precise heart health assessments and identifying disorders such as arrhythmias.
• Additionally, the HealthSuite platform from Philips analyzes cardiac data using AI to provide insights that help improve diagnostic and treatment plans.

Rising Prevalence of Cardiovascular Diseases Is Major Driver for Market

• The increasing incidence of cardiovascular disorders is a major factor driving the need for continuous cardiac monitoring systems.
• By 2035, more than 130 million adults, or 45.1% of the U.S. population, are projected to have some form of CVD.
• This increase highlights the critical need for advance monitoring systems that can facilitate prompt cardiac disease diagnosis and efficient treatment.
• Cardiac monitoring systems have become increasingly essential to address these challenges.
• These systems offer real-time tracking of heart rhythms, blood pressure, and other vital signs, which provides healthcare providers with valuable insights into a patient’s cardiovascular health.
• Advanced technologies driving this market expansion include implantable cardiac devices, wearable ECG monitors, and mobile telemetry systems.
• In addition to enabling prompt medical actions, continuous monitoring gives patient the ability to better manage their health through regular data input.
• This proactive approach can lead to better management of risk variables, individualized treatment programs, and ultimately better patient outcomes.

High Cost of Advanced Monitoring Technologies Is Major Challenge for Market

• Advanced cardiac monitoring devices, such as wearable ECG monitors, implantable cardiac monitors, and advanced mobile telemetry systems, involve heavy financial investments.
• This includes expenses for manufacturing, R&D, and integration with healthcare systems.
• For instance, the initial cost and continuous upkeep of implanted devices and advanced wearables can be expensive.
• Furthermore, the expensive price of these technologies may prevent them from being accessible, especially in areas with limited healthcare funding, particularly in low- and middle-income regions.
• This creates disparities in access to advanced cardiac monitoring, leaving underserved areas without essential health management tools.

Cardiac Monitoring Market Analysis

Product Analysis

• The resting ECG category will account for around 40% revenue share in 2024. This is attributed to the quick and enhanced diagnosis of cardiac health via these devices in comparison to other short- & longer-term monitoring devices.
• Additionally, the costs associated with resting ECG devices are comparatively lower as compared to others.
• Moreover, these instruments can be used with numerous other cardiac diagnostic tests, telemetry monitoring equipment, and in medical procedures.
• MCT is the fastest-growing category, with a CAGR of 6% in the forecast period.
• MCT systems are becoming popular because they provide continuous, real-time monitoring of cardiac rhythms and data transfer.
• This is primarily because they can provide more accurate diagnosis and prompt feedback than older approaches.

The products analyzed in this report are:

• Resting ECG (Largest Category)
• Stress ECG
• MCT (Fastest-Growing Category)
• Holter Monitoring
• ICM Monitoring
• Cardiac Event Monitoring
• Cardiac Output Monitoring

Mode Analysis

• The standard category will hold the larger market share of around one third, in 2024 due to its established presence in healthcare settings, broad application, and integration into routine cardiovascular care.
• This category includes traditional methods such as resting ECGs and Holter monitors.
• Ambulatory is the faster-growing category, with a CAGR of 5.5% in the forecast period because of advances in technology, increased patient preference for remote monitoring, and the rise of telemedicine.
• Ambulatory monitoring includes MCT and wearable ECG devices.
• These devices support patient-centered care and remote healthcare trends by offering more flexibility and continuous, real-time data.

The modes analyzed in this report are:

• Standard (Larger Category)
• Ambulatory (Faster-Growing Category)

End User Analysis

• Hospitals will generate around 10.0 billion revenue in 2024, and this number will grow at a CAGR of 4% during 2025–2030.
• Their high revenue contribution is due to the rising prevalence of CVDs, surging number of patient visits to hospitals, rising number of cardiac device implantation procedures, and easy availability of reimbursement for these procedures.
• Around 6.9% of the patients who suffer from ischemic heart disease, coronary artery disease, or a history of myocardial infarction visit hospitals in the U.S. every year, while around 7.2% of the patients with heart diseases visit emergency departments.
• Hospitals are witnessing a rise in implantations and associated follow-up care as a result of technological advancements and increased patient eligibility for these procedures.

The end users analyzed in this report are:

• Hospitals (Largest and Fastest-Growing Category)
• Specialty Cardiac Centers & Clinics
• Diagnostic Centers
• Others

Regional Analysis

• North America is the largest market with share, of 35%, in 2024.
• The major share of the region is on account of the rising prevalence of CVDs, increasing healthcare expenditure, mounting disposable income, growing healthcare awareness, and the availability of technologically advanced devices.
• The AHA reports that approximately 82.6 million people in the U.S. currently have one or more CVDs, making it a leading cause of death for both men and women.
• Furthermore, North America's access to modern technology strengthens the region's position as a market leader.
• The region's significant market share and growth potential can also be attributed to innovations including implanted monitors, advanced wearables, and real-time mobile cardiac telemetry, which are easily accessible.
• APAC is the expected to grow at a CAGR of 6.5% by 2030 due to the rising healthcare expenditure, increasing prevalence of CVD and advancement in healthcare.
• Countries such as India and China have a large patient population, along with an expanding healthcare expenditure.
• It is estimated that approximately 330 million individuals in China are affected by CVDs, including 13 million strokes and 11.39 million coronary heart disease.

The regions and countries analyzed in this report are:

• North America (Largest Regional Market)
  • U.S. (Larger Country Market)
  • Canada (Faster-Growing Country Market)
• Europe
  • U.K.
  • Germany (Largest Country Market)
  • France (Fastest-Growing Country Market)
  • Spain
  • Italy
  • Rest of Europe
• Asia-Pacific (APAC) (Fastest-Growing Regional Market)
  • China (Largest Country Market)
  • India (Fastest-Growing Country Market)
  • Japan
  • South Korea
  • Australia
  • Rest of APAC
• Latin America (LATAM)
  • Brazil (Largest Country Market)
  • Mexico (Fastest-Growing Country Market)
  • Rest of LATAM
• Middle East and Africa (MEA)
  • Saudi Arabia (Largest Country Market)
  • South Africa
  • U.A.E. (Fastest-Growing Country Market)
  • Rest of MEA

Cardiac Monitoring Market Share

The cardiac monitoring market is consolidated in nature due to the presence of a few dominant players controlling a substantial portion of the market. To hold a competition, major corporations make use of their well-established brand names, vast distribution networks, and significant R&D expenditures. Additionally, strategic mergers and acquisitions, which improve product offerings, expedite operations, and broaden market reach, are further factors driving this consolidation.

Cardiac Monitoring Market News

• In May 2024, Medtronic plc added AI to Linq insertable cardiac monitor to reduce false alerts.
• In January 2024, Medtronic plc and CDL collaborated to launch indigenously developed advanced heart rhythm monitoring technology in India.
• In October 2023, Boston Scientific Corporation launched LUX-Dx II+ insertable cardiac monitor system.
• In May 2023, Abbott Laboratories introduced the Asert-IQ, a Bluetooth-enabled, insertable cardiac monitor designed for long-term heart rhythm monitoring.
• In August 2022, Merit Medical Systems Inc. launched the SafeGuard Focus Cool Compression Device, an addition to its SafeGuard platform. This device complements Merit Medical’s broader cardiac portfolio, which includes tools and accessories for interventional cardiac resynchronization therapy, electrophysiology, and cardiac rhythm management.